Which anti‑helminthic agents are safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Antihelminthic Agents in Pregnancy

Albendazole and praziquantel are the safest antihelminthic agents for use during pregnancy, particularly after the first trimester, with albendazole demonstrating cure rates up to 90% for hookworm and Ascaris infections without serious adverse events. 1

First-Line Antihelminthic Agents

Albendazole

  • Albendazole is the preferred agent for soil-transmitted helminths during pregnancy, with demonstrated cure rates of up to 90% for hookworm and Ascaris lumbricoides, though only 50% efficacy for Trichuris trichiura 1
  • Treatment with albendazole during the second or third trimester shows no increased risk of pregnancy loss, preterm delivery, or adverse maternal outcomes compared to placebo 1, 2
  • Pooled analysis demonstrates a 90% relative risk reduction in hookworm prevalence at delivery when albendazole is used versus placebo 1
  • No serious adverse events have been attributable to albendazole use in pregnant women across multiple studies 1

Praziquantel

  • Praziquantel is considered the safest of all antihelminthics and is classified as FDA Pregnancy Category B, indicating presumed safety based on animal studies 3
  • Over two decades of clinical experience with praziquantel suggests very low potential for adverse effects on mother or fetus 3
  • Praziquantel is specifically recommended for schistosomiasis treatment during pregnancy, as untreated schistosomiasis causes significant morbidity to both mother and fetus 3
  • The drug should be administered to pregnant women in endemic areas, and women of childbearing age should be included in mass treatment programs 3

Mebendazole

  • Mebendazole demonstrates overall cure rates of ≤70% for Ascaris, hookworm, and Trichuris, making it less effective than albendazole 1
  • No increased rates of pregnancy loss or adverse maternal outcomes have been documented with mebendazole use 1, 2
  • Mebendazole can be considered as an alternative when albendazole is unavailable 1

Timing of Treatment

Second and Third Trimester

  • All antihelminthic treatments should be administered during the second or third trimester of pregnancy, not during the first trimester when organogenesis occurs 1, 2
  • Single-dose administration in the second trimester is the standard approach for mass treatment programs 2

First Trimester Considerations

  • Avoid all antihelminthic agents during the first trimester due to theoretical teratogenic concerns, despite lack of documented human teratogenicity 2, 4

Agents with Limited Data or Higher Risk

Ivermectin

  • Ivermectin shows lower cure rates in pregnancy: only 29% for hookworm and 56% for Trichuris 1
  • Ivermectin is versatile for filariasis and intestinal worms but has less robust safety data in pregnancy compared to albendazole and praziquantel 5

Triclabendazole

  • Triclabendazole shows promise for distomiasis (liver fluke) treatment in pregnant women as a substitute for bithionol, which is not recommended during pregnancy 5

Important Clinical Caveats

Iron Supplementation

  • When iron supplementation is provided alongside antihelminthic treatment, the additional benefit of antihelminthics for maternal anemia may be modest in low-intensity infection settings 2
  • However, in endemic areas with significant hookworm burden, antihelminthics remain important for addressing iron-deficiency anemia 1, 2

Potential Adverse Effects

  • One study (Entebbe Mother and Baby Study) found increased rates of infantile eczema following maternal albendazole treatment, though the clinical significance and long-term implications remain unclear 4
  • Praziquantel showed increased eczema rates specifically in infants of mothers with Schistosoma mansoni infection 4
  • These findings require further investigation but do not currently outweigh the benefits of treatment in high-burden settings 4

Lactating Women

  • Praziquantel is safe for lactating women and they should not be systematically excluded from treatment programs 3
  • Albendazole safety data in lactation is limited but no serious concerns have been documented 1

Treatment Algorithm

For pregnant women with confirmed helminth infection:

  1. Confirm gestational age - ensure patient is in second or third trimester 2
  2. Identify helminth species through stool examination when possible 1
  3. For soil-transmitted helminths (hookworm, Ascaris, Trichuris): Use albendazole as first-line agent 1
  4. For schistosomiasis: Use praziquantel 3
  5. Provide concurrent iron supplementation to optimize maternal anemia treatment 2
  6. Counsel patients that treatment benefits outweigh minimal documented risks, particularly in endemic areas with high disease burden 1, 3

References

5
Research

[Antiparasitic treatments in pregnant women and in children in 2003].

Medecine tropicale : revue du Corps de sante colonial, 2003

Related Questions

Is albendazole safe and appropriate for a pregnant woman with a helminth infection, and what are the dosing and safety recommendations for each trimester?
What is the safest anti‑helmintic regimen for a pregnant woman in her first trimester with Ascaris lumbricoides infection?
Is Mebendazol (antiparasitic medication) safe to use during pregnancy?
Is it safe to use praziquantel with progesterone?
What is the recommended treatment and dosage for Ascaris lumbricoides infection in a woman in her first trimester of pregnancy?
In an adult with chronic neuropathic or musculoskeletal pain and no contraindications (e.g., uncontrolled glaucoma, severe hepatic impairment, recent MAO‑inhibitor use, uncontrolled hypertension), what is the recommended SNRI (duloxetine) dosing regimen and what alternative agents can be used if duloxetine is not tolerated or ineffective?
What is the diagnosis and recommended management for a 43‑year‑old male with a 2‑month history of right heel swelling that improves with movement, a firm mobile non‑warm 2 × 1 cm mass, pain 6/10, normal ESR, CRP, and uric acid, bilateral calcaneal osteoarthritis on X‑ray, and who is taking celecoxib 200 mg every 2 hours?
What is the recommended approach to monitor treatment response in a patient with hormone‑receptor‑positive, HER2‑negative breast cancer?
What is the recommended diagnostic and treatment approach for a pleural effusion in an adult over 40 with risk factors such as heart failure, malignancy, infection, recent thoracic surgery, or chronic liver or kidney disease?
What is the safest anti‑helmintic regimen for a pregnant woman in her first trimester with Ascaris lumbricoides infection?
What sedation strategy should be used for adult mechanically ventilated patients in the intensive care unit, including target Richmond Agitation‑Sedation Scale (RASS) level, preferred short‑acting agents and dosing, contraindications, daily interruption, monitoring, delirium management, and weaning plan?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question